Inspire

 
 
Contact

Inspire Pharmaceuticals, Inc.
4222 Emperor Boulevard, Suite 200
Durham, NC 27703

Main phone number: 919-941-9777
Main fax number: 919-941-9797

If you have specific questions or would like additional information regarding AZASITE® (azithromycin ophthalmic solution) 1%, please call 1-888-881-4696 to speak with a healthcare professional.

If you have specific questions or would like additional information regarding ELESTAT® (epinastine HCl ophthalmic solution) 0.05%, please call 1-800-433-8871.

To request additional company information, contact:
Cara Amoroso, Manager of Corporate Communications
Telephone: 919-941-9777, ext. 266
E-mail:

Directions:

From Raleigh or the Raleigh/Durham Airport:

  • Take Aviation Parkway/Airport Boulevard to I-40 West
  • Take the Page Road Exit (Exit 282)
  • At the stop light at the end of the ramp, turn right
  • Continue under the I-40 overpass and get into the left lane
  • At the stoplight, turn left onto Emperor Boulevard
  • Follow Emperor Boulevard until you see a street sign on the right for Swabia Court and a stone marker on the left for "Royal Center"
  • Turn left into Royal Center; then go straight to the end of the center drive. Turn right along the back of the buildings and go through the parking area to the next corner. Inspire's main entrance is Suite 200.

From Chapel Hill/Durham area:

  • Take I-40 East
  • Take the Page Road Exit (Exit 282)
  • At the stop light at the end of the ramp, go straight onto Emperor Boulevard
  • Follow Emperor Boulevard until you see a street sign on the right for Swabia Court and a stone marker on the left for "Royal Center"
  • Turn left into Royal Center; then go straight to the end of the center drive. Turn right along the back of the buildings and go through the parking area to the next corner. Inspire's main entrance is Suite 200.

View Larger Map

Recent News

Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
DURHAM, N.C., Sep 01, 2010 (BUSINESS WIRE) -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the appoin...

Inspire Announces Amendment to Ophthalmic Collaboration
DURHAM, N.C., Aug 25, 2010 (BUSINESS WIRE) -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today it has ent...

Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
- Experienced Pulmonologist and Cystic Fibrosis Drug Development Expert Joins Inspire - DURHAM, N.C., Aug 13, 2010 ...

Inspire Announces Webcast of Presentation at Bank of America Merrill Lynch Specialty Pharmaceuticals Conference
DURHAM, N.C., Aug 05, 2010 (BUSINESS WIRE) -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Adria...